Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity

American Journal of the Medical Sciences

Volumn 343, Issue 2, 2012, Pages 163-166

  Shlapack, Matthew A ^a   Rizvi, Ali A ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Hyperparathyroidism; Osteopenia; Parathyroid hormone

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ADULT; ANAMNESIS; BONE DENSITY; BONE MASS; CASE REPORT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HUMAN; HYPERCALCEMIA; LABORATORY TEST; NEPHROLITHIASIS; NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM; OSTEOPENIA; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; REVIEW;

EID: 84856644010     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31823bbb9b     Document Type: Article

References (23)

1. Parfitt AM, Rao DS, Kleerekoper M. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner 1991;Res 6(suppl 2):S97-S101; discussion S121-4.
2. Rao DS, Wilson RJ, Kleerekoper M, et al. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 1988;67:1294-8. (Pubitemid 19012967)
3. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341:1249-55. (Pubitemid 29489739)
4. Silverberg SJ, Bilezikian JP. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab 2003;88:5348-52. (Pubitemid 37452738)
5. Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol 2010;54:106-9.
6. Bilezikian JP, Khan AA, Potts JT Jr, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 2009;94:335-9.
7. National Kidney Foundation. Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Available at: http:// www.kidney.org/professionals/kdoqi/guidelines-bone/guide1.htm. Accessed May 27, 2011.
8. George JM, Rabson AS, Ketcham A, et al. Calcareous renal disease and hyperparathyroidism. Q J Med 1965;34:291-301.
9. Grimelius L, Johansson H, Lindquist B, et al. Normocalcemic primary hyperparathyroidism. Acta Chir Scand 1973;139:42-4.
10. Johansson H, Thoren L, Werner I, et al. Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria. Surgery 1975; 77:691-6.
11. Mather HG. Hyperparathyroidism with normal serum calcium. Br Med J 1953;16:424-5.
12. Nichols G Jr, Flanagan B. Normocalcemic hyperparathyroidism. Trans Assoc Am Physicians 1967;80:314-22.
13. Pak CY, East DA, Sanzenbacher LJ, et al. Gastrointestinal calcium absorption in nephrolithiasis. J Clin Endocrinol Metab 1972;35:261-70.
14. Wills MR, Pak CY, Hammond WG, et al. Normocalcemic primary hyperparathyroidism. Am J Med 1969;47:384-91.
15. Maruani G, Hertig A, Paillard M, et al. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 2003;88:4641-8. (Pubitemid 37357505)
16. Tordjman KM, Greenman Y, Osher E, et al. Characterization of normocalcemic primary hyperparathyroidism. Am J Med 2004;117: 861-3. (Pubitemid 39602796)
17. Lundgren E, Hagstrom EG, Lundin J, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 2002;26:931-6. (Pubitemid 36920289)
18. Lundgren E, Rastad J, Thrufjell E, et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287-94. (Pubitemid 27114448)
19. Lowe H, McMahon DJ, Rubin MR, et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3002-5.
20. Bilezikian JP, Rubin M, Silverberg SJ. Asymptomatic primary hyperparathyroidism. Arq Bras Endocrinol Metabol 2006;50:647-56. (Pubitemid 44786001)
21. Monchik JM, Gorgun E. Normocalcemic hyperparathyroidism in patients with osteoporosis. Surgery 2004;136:1242-6. (Pubitemid 39647540)
22. Tordjman KM, Yaron M, Izkhakov E, et al. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol 2010;162:925-33.
23. Ekmekci A, Abaci N, Colak-Ozbey N, et al. Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J Endocrinol Invest 2009; 32:611-6.